Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2229–2239. doi: 10.1158/1055-9965.EPI-14-0491

Table 3.

Prevalence and predictors of HBsAg+ among all newly screened Koreans, n=1,551

N (%) Prevalence (95% CI) ORa (95% CI) p-value
Gender
 Male 690 (44.5) 4.9 (3.3, 6.5) 2.0 (1.1, 3.5) 0.018
 Female 861 (55.5) 2.9 (1.8, 4.0) 1.0
Age
 18-29 192 (12.4) 4.2 (1.4, 7.0) 1.1 (0.3, 4.3) 0.839
 30-39 207 (13.3) 3.9 (1.3, 6.5) 0.9 (0.2, 3.3) 0.831
 40-49 315 (20.3) 4.8 (2.4, 7.2) 1.4 (0.4, 4.4) 0.615
 50-59 412 (26.6) 4.9 (2.8, 7.0) 1.0 (0.3, 3.1) 0.939
 60-69 320 (20.6) 1.2 (0.0, 2.4) 0.3 (0.1, 1.1) 0.066
 70+ 105 (6.8) 3.8 (0.1, 7.5) 1.0
Korean Province
 Gyeonggi (Seoul) 725 (49.8) 3.3 (2.0, 4.6) 0.7 (0.4, 1.2) 0.208
 Not Gyeonggi 730 (50.2) 4.2 (2.7, 5.7) 1.0
Years in US
 Less than 5 175 (11.3) 4.6 (1.5, 7.7) 1.2 (0.5, 2.7) 0.740
 5 to 10 327 (21.1) 3.4 (1.4, 5.4) 0.7 (0.4, 1.6) 0.451
 More than 10 898 (57.9) 3.7 (2.5, 4.9) 1.0
 Unknown 151 (9.7) 4.6 (1.3, 7.9) 1.4 (0.6, 3.6) 0.438
Education
 Elementary school 90 (6.0) 3.3 (-0.4, 7.0) 1.1 (0.3, 4.2) 0.855
 Junior high school 109 (7.3) 1.8 (-0.7, 4.3) 0.6 (0.1, 2.8) 0.539
 High school/vocational school 547 (36.7) 4.0 (2.4, 5.6) 1.2 (0.6, 2.1) 0.635
 College 747 (50.0) 4.3 (2.9, 5.8) 1.0
Family History of HBV
 No 1039 (67.4) 3.2 (2.1, 4.3) 1.0
 Yes 113 (7.3) 11.5 (5.6, 17.4) 4.7 (2.3, 9.8) <0.001
 Not sure 390 (25.3) 3.1 (1.4, 4.8) 1.0 (0.5, 2.0) 0.963
a

Adjusted for all other variables in the model